Sugentech Inc (253840) - Net Assets
Based on the latest financial reports, Sugentech Inc (253840) has net assets worth ₩76.54 Billion KRW (≈ $51.87 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩98.21 Billion ≈ $66.56 Million USD) and total liabilities (₩21.67 Billion ≈ $14.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Sugentech Inc's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩76.54 Billion |
| % of Total Assets | 77.94% |
| Annual Growth Rate | N/A |
| 5-Year Change | -24.0% |
| 10-Year Change | N/A |
| Growth Volatility | 59.96 |
Sugentech Inc - Net Assets Trend (2017–2025)
This chart illustrates how Sugentech Inc's net assets have evolved over time, based on quarterly financial data. Also explore 253840 asset base for the complete picture of this company's asset base.
Annual Net Assets for Sugentech Inc (2017–2025)
The table below shows the annual net assets of Sugentech Inc from 2017 to 2025. For live valuation and market cap data, see market cap of Sugentech Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩76.54 Billion ≈ $51.87 Million |
-21.19% |
| 2024-12-31 | ₩97.13 Billion ≈ $65.82 Million |
-13.63% |
| 2023-12-31 | ₩112.45 Billion ≈ $76.21 Million |
-20.00% |
| 2022-12-31 | ₩140.58 Billion ≈ $95.27 Million |
+39.59% |
| 2021-12-31 | ₩100.71 Billion ≈ $68.25 Million |
+59.59% |
| 2020-12-31 | ₩63.11 Billion ≈ $42.77 Million |
+159.63% |
| 2019-12-31 | ₩24.31 Billion ≈ $16.47 Million |
+57.26% |
| 2018-12-31 | ₩15.46 Billion ≈ $10.47 Million |
+147.11% |
| 2017-12-31 | ₩-32.81 Billion ≈ $-22.24 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Sugentech Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4680094174000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩8.76 Billion | 11.48% |
| Other Components | ₩67.55 Billion | 88.52% |
| Total Equity | ₩76.31 Billion | 100.00% |
Sugentech Inc Competitors by Market Cap
The table below lists competitors of Sugentech Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TPL Plastech Limited
NSE:TPLPLASTEH
|
$57.82 Million |
|
Nido Education Ltd
AU:NDO
|
$57.83 Million |
|
Cayson Acquisition Corp Ordinary shares
NASDAQ:CAPN
|
$57.85 Million |
|
CTI Traffic Industries Co Ltd
TWO:2230
|
$57.87 Million |
|
Nila Spaces Limited
NSE:NILASPACES
|
$57.80 Million |
|
Woory Industrial Co. Ltd
KQ:215360
|
$57.80 Million |
|
Hwacheon Mac
KO:000850
|
$57.77 Million |
|
Hankook Furniture Co. Ltd
KQ:004590
|
$57.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sugentech Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 97,126,326,500 to 76,310,236,350, a change of -20,816,090,150 (-21.4%).
- Net loss of 23,314,481,220 reduced equity.
- New share issuances of 1,000,001,600 increased equity.
- Other factors increased equity by 1,498,389,470.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-23.31 Billion | -30.55% |
| Share Issuances | ₩1.00 Billion | +1.31% |
| Other Changes | ₩1.50 Billion | +1.96% |
| Total Change | ₩- | -21.43% |
Book Value vs Market Value Analysis
This analysis compares Sugentech Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.12x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩-6699.09 | ₩5580.00 | x |
| 2018-12-31 | ₩1352.73 | ₩5580.00 | x |
| 2019-12-31 | ₩1880.41 | ₩5580.00 | x |
| 2020-12-31 | ₩4125.87 | ₩5580.00 | x |
| 2021-12-31 | ₩6216.91 | ₩5580.00 | x |
| 2022-12-31 | ₩8640.89 | ₩5580.00 | x |
| 2023-12-31 | ₩7481.63 | ₩5580.00 | x |
| 2024-12-31 | ₩6352.41 | ₩5580.00 | x |
| 2025-12-31 | ₩4990.97 | ₩5580.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sugentech Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -30.55%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -247.58%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 1.29x
- Recent ROE (-30.55%) is above the historical average (-41.74%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | -609.32% | 0.19x | 0.00x | ₩-17.68 Billion |
| 2018 | -264.72% | -750.91% | 0.22x | 1.58x | ₩-42.46 Billion |
| 2019 | -39.34% | -248.66% | 0.08x | 1.87x | ₩-11.99 Billion |
| 2020 | -65.00% | -99.19% | 0.57x | 1.15x | ₩-47.33 Billion |
| 2021 | 35.90% | 46.83% | 0.50x | 1.54x | ₩26.08 Billion |
| 2022 | 19.00% | 26.35% | 0.59x | 1.23x | ₩12.66 Billion |
| 2023 | -15.34% | -241.69% | 0.05x | 1.18x | ₩-28.48 Billion |
| 2024 | -15.64% | -150.47% | 0.09x | 1.11x | ₩-24.91 Billion |
| 2025 | -30.55% | -247.58% | 0.10x | 1.29x | ₩-30.95 Billion |
Industry Comparison
This section compares Sugentech Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $103,716,724,510
- Average return on equity (ROE) among peers: -3.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sugentech Inc (253840) | ₩76.54 Billion | 0.00% | 0.28x | $57.82 Million |
| Shinhung (004080) | $77.28 Billion | 1.29% | 0.82x | $88.63 Million |
| HansBiomed Corporation (042520) | $33.89 Billion | -92.49% | 2.73x | $258.75 Million |
| JVM Co. Ltd (054950) | $104.90 Billion | 4.97% | 0.55x | $195.14 Million |
| Huvitz Co. Ltd (065510) | $78.68 Billion | 3.95% | 0.79x | $58.02 Million |
| Vieworks Co. Ltd (100120) | $126.17 Billion | 15.56% | 0.09x | $165.07 Million |
| Corentec Co Ltd (104540) | $60.18 Billion | 0.77% | 0.59x | $50.52 Million |
| Humasis Co. Ltd (205470) | $346.73 Billion | 52.67% | 0.35x | $61.42 Million |
| NH SPAC 2 (206640) | $151.09 Billion | 29.36% | 0.27x | $169.86 Million |
| Hana Must SPAC 2 (208370) | $26.92 Billion | -55.25% | 0.69x | $75.64 Million |
| DRTECH Corporation (214680) | $31.33 Billion | 3.98% | 0.59x | $98.45 Million |
About Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more